SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-112331
Filing Date
2024-10-03
Accepted
2024-10-03 16:05:23
Documents
11
Period of Report
2024-09-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20240927.htm   iXBRL 8-K 38947
  Complete submission text file 0000950170-24-112331.txt   183250

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240927.xsd EX-101.SCH 44485
13 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240927_htm.xml XML 6209
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 241351428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)